1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Nucleic Acid Isolation and Purification Market Insights
3.1. Industry Value Chain Analysis
3.1.1. DROC Analysis
3.1.2. Growth Drivers
3.1.2.1. Expanding Pipeline for RNA Therapeutics
3.1.2.2. Growing Popularity of Nucleic Acid-based Diagnostics
3.1.2.3. Technological Advancements
3.1.2.4. Increasing Research Activities
3.1.3. Restraints
3.1.3.1. Regulatory Challenges
3.1.3.2. Cost Constraints
3.1.3.3. Supply Chain Disruptions
3.1.4. Opportunities
3.1.4.1. Advanced Diagnostic Techniques Demand
3.1.4.2. Strategic Collaborations
3.1.4.3. Market Expansion in Developing Regions
3.1.5. Challenges
3.1.5.1. High Competition
3.1.5.2. Technological Complexity
3.2. Technological Advancements/Recent Developments
3.3. Regulatory Framework
3.4. Porter's Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrants
3.4.4. Threat of Substitutes
3.4.5. Intensity of Rivalry
4. Global Nucleic Acid Isolation and Purification Market, Pricing Analysis
5. Global Nucleic Acid Isolation and Purification Market: Marketing Strategies
6. Global Nucleic Acid Isolation and Purification Market, Geographical Analysis
6.1. Global Nucleic Acid Isolation and Purification Market, Geographical Analysis, 2023
6.2. Global Lateral Flow Assays, Market Attractiveness Analysis, 2024-2030
7. Global Nucleic Acid Isolation and Purification Market Overview
7.1. Market End User & Forecast, 2019-2030
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.1.1. Kits & Reagents
7.2.1.2. Instruments
7.2.1.3. Others
7.2.2. By Type
7.2.2.1. Plasmid DNA Isolation & Purification
7.2.2.2. Total RNA Isolation & Purification
7.2.2.3. Genomic DNA Isolation & Purification
7.2.2.4. Messenger RNA Isolation & Purification
7.2.2.5. Micro RNA Isolation & Purification
7.2.2.6. Circulating Nucleic Acid Isolation & Purification
7.2.2.7. PCR Cleanup
7.2.2.8. Others
7.2.3. By Method
7.2.3.1. Reagent-based Isolation & Purification
7.2.3.2. Column-based Isolation & Purification
7.2.3.3. Magnetic Bead-based Isolation & Purification
7.2.3.4. Others
7.2.4. By Application
7.2.4.1. Drug Discovery & Development
7.2.4.2. Precision Medicine
7.2.4.3. Diagnostics
7.2.4.4. Agriculture & Animal Research
7.2.4.5. Others
7.2.5. By End User
7.2.5.1. Hospitals
7.2.5.2. Diagnostic Centers
7.2.5.3. Academic & Research Institutes
7.2.5.4. Contract Research Organizations
7.2.5.5. Pharmaceutical & Biotechnology Companies
7.2.5.6. Others
7.2.6. By Region
7.2.6.1. North America
7.2.6.2. Europe
7.2.6.3. Asia Pacific (APAC)
7.2.6.4. Latin America (LATAM)
7.2.6.5. Middle East and Africa (MEA)
8. North America Nucleic Acid Isolation and Purification Market
8.1. Market End User & Forecast, 2019-2030
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Type
8.2.3. By Method
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.2.6.1. United States
8.2.6.1.1. By Product
8.2.6.1.2. By Type
8.2.6.1.3. By Method
8.2.6.1.4. By Application
8.2.6.1.5. By End User
8.2.6.2. Canada
8.2.6.2.1. By Product
8.2.6.2.2. By Type
8.2.6.2.3. By Method
8.2.6.2.4. By Application
8.2.6.2.5. By End User
9. Europe Nucleic Acid Isolation and Purification Market
9.1. Market End User & Forecast, 2019-2030
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Type
9.2.3. By Method
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.2.6.1. Germany
9.2.6.1.1. By Product
9.2.6.1.2. By Type
9.2.6.1.3. By Method
9.2.6.1.4. By Application
9.2.6.1.5. By End User
9.2.6.2. United Kingdom
9.2.6.2.1. By Product
9.2.6.2.2. By Type
9.2.6.2.3. By Method
9.2.6.2.4. By Application
9.2.6.2.5. By End User
9.2.6.3. Italy
9.2.6.3.1. By Product
9.2.6.3.2. By Type
9.2.6.3.3. By Method
9.2.6.3.4. By Application
9.2.6.3.5. By End User
9.2.6.4. France
9.2.6.4.1. By Product
9.2.6.4.2. By Type
9.2.6.4.3. By Method
9.2.6.4.4. By Application
9.2.6.4.5. By End User
9.2.6.5. Spain
9.2.6.5.1. By Product
9.2.6.5.2. By Type
9.2.6.5.3. By Method
9.2.6.5.4. By Application
9.2.6.5.5. By End User
9.2.6.6. Belgium
9.2.6.6.1. By Product
9.2.6.6.2. By Type
9.2.6.6.3. By Method
9.2.6.6.4. By Application
9.2.6.6.5. By End User
9.2.6.7. Russia
9.2.6.7.1. By Product
9.2.6.7.2. By Type
9.2.6.7.3. By Method
9.2.6.7.4. By Application
9.2.6.7.5. By End User
9.2.6.8. The Netherlands
9.2.6.8.1. By Product
9.2.6.8.2. By Type
9.2.6.8.3. By Method
9.2.6.8.4. By Application
9.2.6.8.5. By End User
9.2.6.9. Rest of Europe
9.2.6.9.1. By Product
9.2.6.9.2. By Type
9.2.6.9.3. By Method
9.2.6.9.4. By Application
9.2.6.9.5. By End User
10. Asia Pacific Nucleic Acid Isolation and Purification Market
10.1. Market End User & Forecast, 2019-2030
10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Type
10.2.3. By Method
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.2.6.1. China
10.2.6.1.1. By Product
10.2.6.1.2. By Type
10.2.6.1.3. By Method
10.2.6.1.4. By Application
10.2.6.1.5. By End User
10.2.6.2. India
10.2.6.2.1. By Product
10.2.6.2.2. By Type
10.2.6.2.3. By Method
10.2.6.2.4. By Application
10.2.6.2.5. By End User
10.2.6.3. Japan
10.2.6.3.1. By Product
10.2.6.3.2. By Type
10.2.6.3.3. By Method
10.2.6.3.4. By Application
10.2.6.3.5. By End User
10.2.6.4. South Korea
10.2.6.4.1. By Product
10.2.6.4.2. By Type
10.2.6.4.3. By Method
10.2.6.4.4. By Application
10.2.6.4.5. By End User
10.2.6.5. Australia & New Zealand
10.2.6.5.1. By Product
10.2.6.5.2. By Type
10.2.6.5.3. By Method
10.2.6.5.4. By Application
10.2.6.5.5. By End User
10.2.6.6. Indonesia
10.2.6.6.1. By Product
10.2.6.6.2. By Type
10.2.6.6.3. By Method
10.2.6.6.4. By Application
10.2.6.6.5. By End User
10.2.6.7. Malaysia
10.2.6.7.1. By Product
10.2.6.7.2. By Type
10.2.6.7.3. By Method
10.2.6.7.4. By Application
10.2.6.7.5. By End User
10.2.6.8. Singapore
10.2.6.8.1. By Product
10.2.6.8.2. By Type
10.2.6.8.3. By Method
10.2.6.8.4. By Application
10.2.6.8.5. By End User
10.2.6.9. Vietnam
10.2.6.9.1. By Product
10.2.6.9.2. By Type
10.2.6.9.3. By Method
10.2.6.9.4. By Application
10.2.6.9.5. By End User
10.2.6.10. Rest of APAC
10.2.6.10.1. By Product
10.2.6.10.2. By Type
10.2.6.10.3. By Method
10.2.6.10.4. By Application
10.2.6.10.5. By End User
11. Latin America Nucleic Acid Isolation and Purification Market
11.1. Market End User & Forecast, 2019-2030
11.1.1. By Value (USD Billion)
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Type
11.2.3. By Method
11.2.4. By Application
11.2.5. By End User
11.2.6. By Country
11.2.6.1. Brazil
11.2.6.1.1. By Product
11.2.6.1.2. By Type
11.2.6.1.3. By Method
11.2.6.1.4. By Application
11.2.6.1.5. By End User
11.2.6.2. Mexico
11.2.6.2.1. By Product
11.2.6.2.2. By Type
11.2.6.2.3. By Method
11.2.6.2.4. By Application
11.2.6.2.5. By End User
11.2.6.3. Argentina
11.2.6.3.1. By Product
11.2.6.3.2. By Type
11.2.6.3.3. By Method
11.2.6.3.4. By Application
11.2.6.3.5. By End User
11.2.6.4. Peru
11.2.6.4.1. By Product
11.2.6.4.2. By Type
11.2.6.4.3. By Method
11.2.6.4.4. By Application
11.2.6.4.5. By End User
11.2.6.5. Rest of LATAM
11.2.6.5.1. By Product
11.2.6.5.2. By Type
11.2.6.5.3. By Method
11.2.6.5.4. By Application
11.2.6.5.5. By End User
12. Middle East and Africa Nucleic Acid Isolation and Purification Market
12.1. Market End User & Forecast, 2019-2030
12.1.1. By Value (USD Billion)
12.2. Market Share & Forecast
12.2.1. By Product
12.2.2. By Type
12.2.3. By Method
12.2.4. By Application
12.2.5. By End User
12.2.6. By Country
12.2.6.1. Saudi Arabia
12.2.6.1.1. By Product
12.2.6.1.2. By Type
12.2.6.1.3. By Method
12.2.6.1.4. By Application
12.2.6.1.5. By End User
12.2.6.2. UAE
12.2.6.2.1. By Product
12.2.6.2.2. By Type
12.2.6.2.3. By Method
12.2.6.2.4. By Application
12.2.6.2.5. By End User
12.2.6.3. Qatar
12.2.6.3.1. By Product
12.2.6.3.2. By Type
12.2.6.3.3. By Method
12.2.6.3.4. By Application
12.2.6.3.5. By End User
12.2.6.4. Kuwait
12.2.6.4.1. By Product
12.2.6.4.2. By Type
12.2.6.4.3. By Method
12.2.6.4.4. By Application
12.2.6.4.5. By End User
12.2.6.5. South Africa
12.2.6.5.1. By Product
12.2.6.5.2. By Type
12.2.6.5.3. By Method
12.2.6.5.4. By Application
12.2.6.5.5. By End User
12.2.6.6. Nigeria
12.2.6.6.1. By Product
12.2.6.6.2. By Type
12.2.6.6.3. By Method
12.2.6.6.4. By Application
12.2.6.6.5. By End User
12.2.6.7. Algeria
12.2.6.7.1. By Product
12.2.6.7.2. By Type
12.2.6.7.3. By Method
12.2.6.7.4. By Application
12.2.6.7.5. By End User
12.2.6.8. Rest of MEA
12.2.6.8.1. By Product
12.2.6.8.2. By Type
12.2.6.8.3. By Method
12.2.6.8.4. By Application
12.2.6.8.5. By End User
13. Competitive Landscape
13.1. List of Key Players and Their Methods
13.2. Global Nucleic Acid Isolation and Purification Company Market Share Analysis, 2023
13.3. Competitive Benchmarking, By Operating Parameters
13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
14. Impact of Escalating Geopolitical Tensions on Global Nucleic Acid Isolation and Purification Market
15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
15.1. Agilent Technologies
15.2. Bio-Rad Laboratories Inc.
15.3. Thermo Fisher Scientific
15.4. BioVision Inc.
15.5. Danaher Corporation
15.6. F. Hoffmann-La Roche Ltd
15.7. GE Healthcare
15.8. Merck KGaA (Sigma-Aldrich Corporation)
15.9. Promega Corporation
15.10. Qiagen NV
15.11. Invitek Molecular
15.12. Analytik Jena AG
15.13. Illumina, Inc
15.14. Takara Bio Inc.
15.15. Other Prominent Players
16. Key Strategic Recommendations
17. Research Methodology
17.1. Qualitative Research
17.1.1. Primary & Secondary Research
17.2. Quantitative Research
17.3. Market Breakdown & Data Triangulation
17.3.1. Secondary Research
17.3.2. Primary Research
17.4. Breakdown of Primary Research Respondents, By Region
17.5. Assumptions & Limitations